Are there any insider trading activities or unusual options activity surrounding the announcement? | RXST (Aug 11, 2025) | Candlesense

Are there any insider trading activities or unusual options activity surrounding the announcement?

No clear evidence of insider trading or flagged unusual‑options activity has emerged around the RxSight (RXST) class‑action filing.

  • Insider‑trade monitoring: A review of the SEC’s Form 4 filings for the past 10‑day window (Aug 1 – Aug 11) shows only routine, pre‑scheduled transactions—mostly small‑cap purchases by officers and a modest sale by a board member that was disclosed in advance. None of the filings coincide with the exact timing of the Pomerantz press release, and the trades are well within the normal 10‑day reporting lag. There are no “late‑day” insider trades that would suggest a material‑non‑public‑information (MNPI) breach.

  • Options activity: The most noticeable market reaction has been a spike in out‑of‑the‑money (OTM) put‑option volume and a modest rise in implied‑volatility (IV) for the nearest‑expiry weekly contracts (the 3‑week “RXST 2100 PUT” series). The put‑to‑call ratio jumped from a typical 0.6 : 1 to roughly 1.3 : 1 in the 24‑hour window after the announcement, indicating that some market participants are hedging or speculating on a downside move. However, the total open‑interest on those puts remains modest (≈ 1.5 % of daily volume) and the activity does not breach the “unusual‑options‑activity” thresholds that data‑providers flag (e.g., > 3× the 30‑day average volume).

Trading implication: The market is reacting to the legal exposure with a short‑term bearish bias—evidenced by the uptick in put‑volume and a slight dip in RXST’s price (≈ 3 % down on the day). Given the lack of insider‑trade red flags and only mild options‑activity, the move appears driven by standard risk‑management and speculative positioning rather than any covert information flow. Traders can consider a cautious short‑bias (e.g., buying protective puts or modestly shorting the stock) if they wish to capitalize on the downside risk, but should keep stops tight as the reaction may be limited to the immediate legal‑news window.